百泰基因BIOTGENE品牌怎么样 申请店铺

武汉百泰基因工程有限公司成立于2009年10月，已累计投入5000余万元。是一家专业从事肿瘤个性化基因检测试剂、药物基因组学分析试剂、病原体耐药及致癌突变检测试剂的研发、生产及销售的创新型技术企业，是华中地区基因诊断试剂种类较多、产品较全、研发实力较强的生产企业。

目前，公司现有员工58人，其中外聘教授3人（含湖北省百人计划1人），副教授1人，博士4人，硕士22人，本科12人。2012年12月，公司创新产品“细小脲原体核酸检测试剂盒（PCR-荧光探针法）”被国家科技部、环保部、商务部、质检总局联合评定为“国家新产品”。公司的ARMS-PCR技术研发的乙肝致癌T1896及BCP1762/1764两个产品，是全国一家获证三类产品。

公司自成立以来，已累计经获得24个国家药监局颁发的三类医疗器械注册产品证书，是华中地区拥有注册产品较多的基因诊断试剂企业。

Wuhan Baitai Genetic Engineering Co., Ltd. was founded in October 2009, and has invested more than 50 million yuan. It is an innovative technology enterprise specializing in the research and development, production and sales of tumor personalized gene detection reagents, drug genomics analysis reagents, pathogen resistance and carcinogenic mutation detection reagents. It is also a manufacturer with a wide range of gene diagnosis reagents, complete products and strong R & D strength in Central China. At present, the company has 58 employees, including 3 external professors (including 1 in Hubei hundred talents plan), 1 associate professor, 4 doctors, 22 masters and 12 undergraduates. In December 2012, the company's innovative product "Mycoplasma parvum nucleic acid detection kit (PCR fluorescence probe method)" was jointly evaluated as "national new product" by the Ministry of science and technology, the Ministry of environmental protection, the Ministry of Commerce and the General Administration of quality supervision, inspection and Quarantine of the people's Republic of China. The company's ARMS-PCR technology research and development of hepatitis B carcinogenic t1896 and bcp1762 / 1764 two products, is one of the three certified products. Since its establishment, the company has obtained three kinds of medical device registration product certificates issued by 24 state food and drug administration. It is a gene diagnosis reagent enterprise with more registered products in Central China.

本文链接： https://brand.waitui.com/c2ea91057.html 联系电话：027-59726585,59206901